1 option
Examining the FDA's Regulation of Over-The-Counter Monograph Drugs: Hearing Before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Nineteenth Congress, First Session [2025].
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.